Obesity Ups Respiratory Events in Peds Procedural Sedation

This article originally appeared here.
Share this content:
Obesity Ups Respiratory Events in Peds Procedural Sedation
Obesity Ups Respiratory Events in Peds Procedural Sedation

WEDNESDAY, April 1, 2015 (HealthDay News) -- Obesity is associated with increased odds of respiratory events and more frequent need for airway intervention in patients undergoing pediatric procedural sedation, according to a study published online March 27 in Pediatric Anesthesia.

Patricia D. Scherrer, M.D., from Children's Hospitals and Clinics of Minnesota in Minneapolis, and colleagues queried the Pediatric Sedation Research Consortium database to compare sedation-related outcomes, adverse events, and therapeutic interventions for obese and nonobese patients. Of the 28,792 records that were eligible, 5,153 patients were obese.

The researchers found that total adverse events were more frequent in obese patients (odds ratio [OR], 1.49). Obese patients had increased respiratory events (airway obstruction: OR, 1.94; oxygen desaturation: OR, 1.99; secretions: OR, 1.48; and laryngospasm: OR, 2.30), inability to complete the associated procedure (OR, 1.96), and prolonged recovery (OR, 2.66). Airway interventions, including repositioning, suctioning, jaw thrust, airway adjuncts, and bag-valve-mask ventilation, were more frequently required in obese patients. In multivariate analysis, obesity was independently associated with minor and moderate, but not major, adverse events.

"Obesity is an independent risk factor for adverse respiratory events during procedural sedation and is associated with an increased frequency of airway interventions, suggesting that additional vigilance and expertise are required when sedating these patients," the authors write.

Abstract
Full Text (subscription or payment may be required)

Share this content:

is free, fast, and customized just for you!




Already a member?

Sign In Now »

Trending Activities

All Professions

Drug Lookup

Browse drugs by: BrandGenericDisease

More in Home

FDA Permits Marketing of Brain Stimulation Device for OCD

FDA Permits Marketing of Brain Stimulation Device for ...

FDA previously approved transcranial magnetic stimulation for major depression, certain migraines

Comments Open on End of NIH Review for Gene Therapy Studies

Comments Open on End of NIH Review for ...

NIH oversight panel no longer plans to review all applications for gene therapy experiments

U.S. Measles Outbreak Hits 107 Cases in 21 States, D.C.

U.S. Measles Outbreak Hits 107 Cases in 21 ...

Outbreak on track to exceed last year's; most of the people who got measles weren't vaccinated

is free, fast, and customized just for you!




Already a member?

Sign In Now »